No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
94 |
4. Check minimum number of eventsNone |
94 |
5. Include endpointsNone |
94 |
6. Filter based on genotype QC (FinnGen only) |
94 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Lichenoid drug reaction
based on the number of shared cases.
Similar with more cases:
- Lichen planus
- Lichen planus, including avohilmo
- Lichen ruber planus, wide definition including periferal and oral lichen planus
- Papulosquamous disorders
- Diseases of the skin and subcutaneous tissue
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 477 | 331 | 146 |
| Only index persons | 447 | 310 | 137 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | - | 60.35 | 59.94 |
| Only index persons | 59.71 | 59.82 | 59.48 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 94 | 66 | 28 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | 58.16 | 57.86 | 58.86 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 85
- Matched controls
- 847
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L43.2
ICD-10 Finland
Lichenoid drug reaction
+∞
122.3
85
*
L43.8
ICD-10 Finland
Other lichen planus
43.3
20.7
25
8
L43.9
ICD-10 Finland
Lichen planus, unspecified
26.6
14.1
19
9
EKA10
NOMESCO Finland
Biopsy of cheek
16.0
10.7
17
13
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
37.2
8.3
10
*
A07AA02
ATC
nystatin; oral
7.3
8.0
19
32
L43.0
ICD-10 Finland
Hypertrophic lichen planus
20.7
7.8
11
6
D07AD01
ATC
clobetasol; topical
4.1
7.0
30
99
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
5.6
6.9
20
44
XQ802
NOMESCO Finland
Epicutan test
10.5
6.5
12
13
ECA20
NOMESCO Finland
Biopsy of gingiva
19.8
6.4
9
5
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
33
114
3.92
8.51
5.7
5.1
%
28.5
33.4
1.26
15
68
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
30
106
3.69
7.38
7.5
8.1
—
—
—
0
0
(3019225) pH of Specimen
26
85
3.85
7.14
8.0
3.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
8
13.79
6.24
2.1
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
9
272
0.26
4.78
2.7
3.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
47
661
0.42
4.06
18.9
19.2
%
13.7
13.9
0.67
47
647
(4146454)
7
9
8.29
3.62
3.6
3.0
—
—
—
0
0
(3013512) EKG study
45
273
2.24
3.59
4.6
4.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
23
108
2.50
3.24
1.4
1.4
titre
288.0
638.7
—
5
31
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
5
10.45
3.01
1.0
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
46
297
2.07
3.00
3.8
3.5
ng/l
1806.5
1293.9
0.34
30
254
(3012516) Albumin [Mass/volume] in Urine
43
273
2.06
2.91
3.0
3.0
mg/l
116.1
59.2
0.25
20
169
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
34
198
2.12
2.89
1.9
2.1
—
—
—
0
0
(4010399)
15
60
2.78
2.87
1.4
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
42
272
1.98
2.64
3.0
2.9
mmol/l
6.8
7.0
0.11
27
216
(3044640) Blood type and Crossmatch panel - Blood
41
264
1.98
2.61
1.9
2.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
44
293
1.94
2.52
3.6
3.8
mg/mmol
19.2
9.5
0.24
20
176
(42870588) Differential panel, method unspecified - Blood
40
259
1.95
2.48
6.3
5.2
—
—
—
0
0
(3044889) 12 lead EKG panel
46
606
0.53
2.38
4.1
4.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
9
5.79
2.24
1.4
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
51
367
1.85
2.23
2.9
2.3
nmol/l
80.6
78.0
0.27
40
314
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
52
384
1.79
2.03
3.1
3.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
73
2.26
1.93
3.3
3.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
75
626
1.98
1.90
6.6
4.5
mm/h
15.5
13.6
0.51
64
559
(3037467) Urinalysis macro (dipstick) panel - Urine
70
574
1.86
1.84
6.8
4.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
11
48
2.46
1.78
1.9
3.0
e9/l
3.0
3.6
—
6
33
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
78
665
2.02
1.78
8.5
7.5
u/l
77.3
79.4
0.21
64
612
(3000330) Specific gravity of Urine by Test strip
0
46
0.00
1.76
0.0
4.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
29
189
1.77
1.67
6.9
3.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
53
409
1.68
1.65
9.4
5.2
mmol/l
1.2
1.2
0.41
41
369
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
26
2.82
1.61
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
33
2.55
1.58
1.5
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
30
201
1.72
1.56
2.3
3.2
umol/l
356.2
12835.5
1.82
24
157
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
15
3.46
1.54
1.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
22
2.84
1.46
1.7
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
29
2.52
1.42
1.6
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
33
234
1.63
1.38
7.0
4.3
estimate
0.0
0.0
—
7
78
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
17
3.05
1.37
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
18
108
1.82
1.34
1.2
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
8
36
2.33
1.28
5.4
2.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
56
458
1.55
1.24
10.6
5.7
mmol/l
1.2
1.2
0.44
39
379
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
45
352
1.53
1.21
3.6
4.3
ng/l
18.0
36.2
1.21
37
272
(3009261) Glucose [Presence] in Urine by Test strip
52
422
1.52
1.17
5.8
4.2
estimate
0.0
0.0
—
8
77
(3004588) Protein electrophoresis panel - Serum or Plasma
12
66
1.94
1.15
1.2
2.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
24
164
1.62
1.14
1.3
1.2
u/ml
1.2
2.0
—
9
46
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
84
769
1.87
1.05
14.0
15.1
ml/min/173m2
70.1
75.0
1.29
62
637
(40768797) Stomach Pathology biopsy report
19
125
1.65
1.04
1.3
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
48
391
1.47
1.01
4.2
3.8
g/l
35.2
35.2
0.01
38
361
(36660697) Celiac disease serology panel - Serum
9
51
1.84
0.98
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
9
52
1.81
0.95
5.2
2.8
—
7.4
—
0
7
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
9
52
1.81
0.95
5.2
2.8
kpa
4.8
5.2
—
9
46
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
28
2.22
0.93
3.8
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
56
1.88
0.92
5.2
3.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
36
282
1.45
0.91
2.1
2.3
u/l
55.0
56.1
0.10
28
257
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
85
792
1.76
0.88
5.9
5.0
mmol/l
1.5
1.5
0.09
69
714
(3015377) Calcium [Moles/volume] in Serum or Plasma
39
312
1.43
0.88
2.6
3.1
mmol/l
2.4
2.4
1.39
29
264
(3015736) pH of Urine
41
332
1.42
0.86
6.0
3.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
10
58
1.81
0.83
2.8
3.0
g/l
10.9
9.7
—
10
50
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
55
471
1.40
0.83
4.7
5.9
umol/l
11.2
10.6
0.23
46
444
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
83
769
1.68
0.82
5.1
4.4
mmol/l
1.2
1.3
0.38
66
691
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
33
1.87
0.80
3.8
2.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
27
0.00
0.79
0.0
5.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
85
797
1.69
0.77
5.6
5.0
mmol/l
4.6
4.6
0.18
68
728
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
70
631
1.43
0.74
5.2
4.1
pmol/l
15.0
15.0
0.06
60
568
(3035350) Ketones [Presence] in Urine by Test strip
49
417
1.37
0.74
5.8
4.1
estimate
0.0
0.0
—
8
84
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
5
25
2.05
0.74
1.4
1.3
—
0.0
—
0
5
(3021601) Nitrite [Presence] in Urine by Test strip
49
418
1.36
0.72
7.1
5.5
estimate
0.0
0.0
—
8
82
(40768443) Skin Pathology biopsy report
7
41
1.76
0.71
1.6
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
41
1.76
0.71
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
27
1.90
0.69
1.4
2.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
22
282
0.71
0.65
2.5
3.0
u/l
44.5
31.5
0.43
22
266
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
57
504
1.33
0.63
3.7
3.1
u/l
57.2
52.0
0.14
44
468
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
42
356
1.32
0.63
1.8
2.0
pmol/l
98.5
98.8
0.01
17
165
(1002224) Polysomnography panel
0
22
0.00
0.60
0.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
86
817
1.62
0.59
6.1
5.7
mmol/l
2.6
2.7
0.13
69
737
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
25
197
1.37
0.59
1.4
1.9
pmol/l
830000315.2
455.9
0.78
20
159
(3019309) Folate [Moles/volume] in Red Blood Cells
23
180
1.37
0.57
2.0
1.7
nmol/l
1166.9
1230.0
0.10
16
131
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
85
809
1.53
0.57
17.7
15.1
mg/l
20.0
23.9
0.48
67
641
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
19
144
1.40
0.56
1.9
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
19
144
1.40
0.56
1.3
1.4
iu/ml
68.7
41.3
—
6
58
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
26
208
1.35
0.56
2.5
2.1
mg/l
2.7
3.5
1.78
18
179
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
84
795
1.53
0.56
6.3
5.2
mmol/l
6.1
6.1
0.13
68
722
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
63
1.47
0.54
1.9
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
11
75
1.53
0.53
2.3
2.1
g/l
0.2
0.2
0.22
11
70
(40761511) CBC panel - Blood by Automated count
87
831
1.63
0.52
17.8
14.3
—
—
—
0
0
(3000492) Spirometry study
10
67
1.55
0.52
1.9
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
41
354
1.28
0.51
2.3
2.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
15
111
1.42
0.50
2.8
4.4
ug/l
7.4
13.2
—
10
91
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
68
1.53
0.49
1.8
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
38
329
1.26
0.46
6.6
4.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
10
70
1.48
0.44
1.8
1.5
—
—
—
0
0
(3020891) Body temperature
5
32
1.59
0.43
4.2
4.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.1
—
39.6
—
0
15
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
10
71
1.46
0.41
10.7
6.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
34
1.50
0.41
2.8
3.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
3.1
—
53.0
—
0
19
(3009542) Hematocrit [Volume Fraction] of Blood
74
698
1.28
0.39
15.9
16.3
%
39.2
39.1
0.01
33
456
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
41
1.49
0.37
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
16
127
1.31
0.36
2.1
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
42
1.46
0.36
3.2
2.6
%
0.9
0.9
—
6
42
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
45
1.36
0.34
1.7
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
18
217
0.79
0.34
1.4
1.5
nmol/l
23.3
23.0
0.02
11
173
(3007164) IgA [Mass/volume] in Serum or Plasma
18
147
1.28
0.34
1.6
1.5
g/l
2.3
2.4
0.14
11
82
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
82
788
1.32
0.32
7.5
6.5
mmol/mol
40.7
40.8
0.02
65
730
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
17
139
1.27
0.32
1.3
1.4
u/ml
1.3
17.2
—
8
50
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
108
0.72
0.31
1.5
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
66
1.23
0.27
1.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
15
124
1.25
0.26
1.5
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
12
98
1.26
0.22
1.3
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
2.6
—
733.4
—
0
5
(40768800) Prostate Pathology biopsy report
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
2.4
—
107.5
—
0
14
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
2.4
—
4.0
—
0
14
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
51
1.19
0.20
2.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
60
1.18
0.18
2.0
1.5
—
—
—
0
0
(3012544) pH of Venous blood
10
82
1.25
0.18
3.6
3.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
17
193
0.85
0.17
6.2
5.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
31
335
0.89
0.16
3.9
2.6
ug/l
104.7
103.8
0.02
25
303
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
42
395
1.11
0.16
3.1
2.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
33
307
1.12
0.15
4.3
3.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
78
760
1.15
0.15
6.4
5.0
mu/l
2.1
2.0
0.13
62
678
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
8
96
0.82
0.14
5.0
3.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
12
137
0.86
0.13
3.2
3.2
e6/l
1.7
3.7
—
6
73
(3030981) Hyaline casts [#/volume] in Urine by Automated count
5
47
1.07
0.09
2.6
3.4
e6/l
0.8
0.1
—
5
47
(3018095) Leukocytes [#/volume] in Urine
30
316
0.93
0.08
4.7
4.0
e6/l
63.1
58.7
0.04
25
221
(40761536) Microorganisms panel - Urine sediment
6
72
0.82
0.08
4.2
4.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
22
234
0.92
0.07
3.9
4.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
9
87
1.04
0.07
12.8
5.7
g/l
123.4
116.8
—
9
87
(3026782) Osmolality of Urine
18
168
1.09
0.06
3.1
3.1
mosm/kgh2o
505.2
517.1
0.10
18
143
(3007853) Bacteria identified in Skin by Aerobe culture
10
90
1.12
0.06
1.8
1.4
—
—
—
0
0
(4035726)
10
90
1.12
0.06
1.3
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
14
151
0.91
0.05
3.8
5.3
%
23.6
21.3
—
9
75
(3023368) Bacteria identified in Blood by Culture
24
229
1.06
0.05
2.7
3.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
18
190
0.93
0.04
1.2
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
39
379
1.05
0.04
7.3
8.5
inr
1.1
1.3
—
8
114
(40758558) Short blood count panel - Blood
21
201
1.06
0.03
6.3
7.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
11
102
1.09
0.03
1.9
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
10
108
0.92
0.03
1.0
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
16
152
1.06
0.02
3.6
2.9
e6/l
0.8
1.0
—
9
86
(36304419) Bacteria [Presence] in Urine
25
243
1.04
0.01
4.3
3.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
104
1.07
0.01
2.0
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
30
297
1.01
0.00
3.0
3.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
68.0
—
0
5
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
6.0
—
53.2
—
0
6
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
6
59
1.02
0.00
13.8
5.9
%
1.1
1.5
—
6
59
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
37.8
—
0
6
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
99.8
—
0
5
(3020491) Glucose [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.7
—
7.4
—
0
7
(4027681)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
9.0
—
0
9
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
18.3
—
0
6
(4024509)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
13.0
—
0
5
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
87
861
1.14
0.00
14.0
11.3
u/l
24.4
23.6
0.24
76
825
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
1.1
—
0
5
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
5
0.00
0.00
0.0
2.0
—
202.9
—
0
5
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint LICHENOID_DRUG_REACTION and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| LICHENOID_DRUG_REACTION | 1.212 [0.91, 1.62] | 0.194 |
| Birth year | 0.994 [0.99, 1.0] | 0.168 |
During the follow-up period (1.1.1998 — 31.12.2019), 65 out of 311 females with LICHENOID_DRUG_REACTION died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have LICHENOID_DRUG_REACTION.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.102% | No data |
| 5 | 0.546% | No data |
| 10 | 1.518% | No data |
| 15 | 3.23% | No data |
| 20 | 5.826% | No data |
Relationships between endpoints
↥Index endpoint: LICHENOID_DRUG_REACTION – Lichenoid drug reaction
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data